COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,306 Articles (22,772 medRxiv, 8,534 bioRxiv)

Most recent first Previous |  Page 1659: Articles 16581-16590  | Next

The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against novel viral variants
Rosenfeld, R., Mazor, O., Makdasi, E., Zvi, A., Alcalay, R., Noy-Porat, T., Peretz, E., Mechaly, A., Levy, Y., Epstein, E., Chitlaru, T., Paran, N., Tamir, H., Zimhony, O., Weiss, S., Mandelboim, M., Mendelson, E., Zuckerman, N., Nemet, I., Kliker, L., Yitzhaki, S., Shapira, S. C., Israely, T.
10.1101/2021.04.01.438035 — Posted: 2021-04-01
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429
McCallum, M., Bassi, J., De Marco, A., Chen, A., Walls, A. C., Di Iulio, J., Tortorici, M. A., Navarro, M.-J., Silacci-Fregni, C., Saliba, C., Agostini, M., Pinto, D., Culap, K., Bianchi, S., Jaconi, S., Cameroni, E., Bowen, J. E., Tiles, S. W., Pizzuto, M. S., Bernasconi Guastalla, S., Bona, G., Franzetti Pellanda, A., Garzoni, C., Van Voorhis, W. C., Rosen, L. E., Snell, G. C., Telenti, A., Virgin, H. W., Piccoli, L., Corti, D., Veesler, D.
10.1101/2021.03.31.437925 — Posted: 2021-04-01
To knot and not: Multiple conformations of the SARS-CoV-2 frameshifting RNA element
Schlick, T., Zhu, Q., Dey, A., Jain, S., Yan, S., Laederach, A.
10.1101/2021.03.31.437955 — Posted: 2021-04-01
Interim Report: Safety And Immunogenicity Of An Inactivated Vaccine Against Sars-Cov-2 In Healthy Chilean Adults In A Phase 3 Clinical Trial
Bueno, S. M., Abarca, K., Gonzalez, P. A., Galvez, N. M. S., Soto, J. A., Duarte, L. F., Schultz, B. M., Pacheco, G. A., Gonzalez, L. A., Vasquez, Y., Rios, M., Melo-Gonzalez, F., Rivera-Perez, D., Iturriaga, C., Urzua, M., Dominguez, A., Andrade, C. A., Berrios, R. V., Canedo-Marroquin, G., Covian, C., Moreno-Tapia, D., Saavedra, F., Vallejos, O. P., Donato, P., Espinoza, P., Fuentes, D., Gonzalez, M., Guzman, P., Munoz-Venturelli, P., Perez, C. M., Potin, M., Rojas, a., Fasce, R., Fernandez, J., Mora, J., Ramirez, E., Gaete-Argel, A., Oyarzun-Arrau, A., Valiente-Echeverria, F., Soto-Rifo, R., Weiskopf, D., Sette, A., Zeng, G., Meng, W., Gonzalez-Aramundiz, J. V., Kalergis, A. M.
10.1101/2021.03.31.21254494 — Posted: 2021-04-01
Accessibility, inclusivity, and implementation of COVID-19 clinical management guidelines early in the pandemic: a global survey
Pilbeam, C., Malden, D., Newell, K., Dagens, A., Kennon, K., Michelen, M., Gobat, N., Sigfrid, L.
10.1101/2021.03.31.21254680 — Posted: 2021-04-01
Short-term antibody response and tolerability of one dose of BNT162b2 vaccine in patients receiving hemodialysis
Goupil, R., Benlarbi, M., Beaubien-Souligny, W., Nadeau-Fredette, A.-C., Debashree, C., Goyette, G., Lamarche, C., Finzi, A., Suri, R. S.
10.1101/2021.03.30.21254652 — Posted: 2021-04-01 Discussion: Onsite
Estimating the strength of selection for new SARS-CoV-2 variants
van Dorp, C. H., Goldberg, E. E., Hengartner, N., Ke, R., Romero-Severson, E. O.
10.1101/2021.03.29.21254233 — Posted: 2021-04-01
Detection of cross-reactive IgA in saliva against SARS-CoV-2 Spike1 subunit
Tsukinoki, K., Yamamoto, T., Handa, K., Iwamiya, M., Ino, S., Sakurai, T.
10.1101/2021.03.29.21253174 — Posted: 2021-04-01
Emerging SARS-CoV-2 mutation hotspots associated with clinical outcomes
Pang, X., Li, P., Zhang, L., Que, L., Dong, M., Wang, Q., Wei, Y., Xie, B., Xie, X., Li, L., Yin, C., Wei, L., Zhou, Q., Li, Y., Yu, L., Li, W., Mo, Z., Leng, J., Hu, Y.
10.1101/2021.03.31.437666 — Posted: 2021-03-31
Differential mutational profile of SARS-CoV-2 proteins across deceased and asymptomatic patients
Laskar, R., Ali, S.
10.1101/2021.03.31.437815 — Posted: 2021-03-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).